Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Seattle Genetics Doses First Patient In Ph II Trial of Antibody-drug Conjugate in Multiple Solid Tumors
CP Wire
Thu, 07/12/18 - 09:17 am
Seattle Genetics
colorectal cancer
non-small cell lung cancer
pancreatic cancer
head and neck cancer
cervical cancer
tisotumab vedotin
Genmab
clinical trials
FDA Grants Priority Review to Keytruda Combination Therapy for Metastatic Squamous Non-Small Cell Lung Cancer
CP Wire
Mon, 07/2/18 - 09:21 am
Merck
Keytruda
non-small cell lung cancer
metastatic squamous non-small cell lung cancer
priority review
FDA
Advaxis Doses First Patient With Customized Immunotherapy Targeting Personal Neoantigens
CP Wire
Mon, 06/11/18 - 09:37 am
Advaxis
ADXS-NEO
immunotherapy
non-small cell lung cancer
clinical trials
ASCO18: 3 unanswered questions from oncology's largest conference
Biopharma Dive
Thu, 06/7/18 - 09:35 am
ASCO 2018
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
immunotherapy combinations
non-small cell lung cancer
FDA Grants Pfizer's Xalkori Breakthrough Therapy Status for Two New Indications
Tue, 05/29/18 - 10:14 am
Pfizer
Xalkori
non-small cell lung cancer
anaplastic large-cell lymphoma
BMY Is Rapidly Advancing Its First-Line NSCLC Research Program
Market Realist
Mon, 05/28/18 - 01:26 pm
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Yervoy
AstraZeneca Announces Positive Results for Imfinzi in Non-Small Cell Lung Cancer
CP Wire
Fri, 05/25/18 - 09:20 am
AstraZeneca
MedImmune
Imfinzi
non-small cell lung cancer
AstraZeneca Announces Positive Results for Imfinzi in Non-Small Cell Lung Cancer
Fri, 05/25/18 - 08:59 am
AstraZeneca
Imfinzi
non-small cell lung cancer
Rain Therapeutics nets $18M to push lung cancer asset into phase 2
Fierce Biotech
Mon, 05/21/18 - 09:15 am
Rain Therapeutics
non-small cell lung cancer
Neon Therapeutics Treats First Patient in Ph Ib Trial Evaluating Personal Cancer Vaccine NEO-PV-01 Plus Keytruda/Chemo Combination
Tue, 05/8/18 - 10:26 am
Neon Therapeutics
cancer vaccines
NEO-PV-01
non-small cell lung cancer
EMA Validates Bristol-Myers Squibb’s Variation Application for Opdivo Plus Yervoy Combination for Treatment of First-Line Metastatic Non-Small Cell Lung Cancer
Thu, 05/3/18 - 09:24 am
Bristol-Myers Squibb
non-small cell lung cancer
Opdivo
Yervoy
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
CP Wire
Wed, 04/25/18 - 09:55 am
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
Tue, 04/24/18 - 11:17 pm
Mirati Therapeutics
Opdivo
checkpoint inhibitors
non-small cell lung cancer
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
CP Wire
Thu, 04/19/18 - 12:30 am
Roche
cobas EGFR Mutation Test
Tagrisso
non-small cell lung cancer
AstraZeneca
Roche Receives FDA Approval for New Indication for cobas EGFR Mutation Test v2 as a Companion Diagnostic With Tagrisso
Thu, 04/19/18 - 12:13 am
Roche
Tagrisso
non-small cell lung cancer
Merck, Bristol-Myers cancer drugs both beat expectations, but Merck beats them a little more
CNBC
Mon, 04/16/18 - 09:46 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Yervoy
non-small cell lung cancer
AACR
We're about to get some key lung cancer data — and it could affect how hundreds of thousands of cancer patients are treated
San Francisco Gate, CA
Sun, 04/15/18 - 10:04 pm
lung cancer
cancer
Merck
Roche
Bristol-Myers Squibb
AACR
non-small cell lung cancer
AstraZeneca's (AZN) Imfinzi Gets FDA Nod for Label Expansion
Yahoo/Zacks.com
Mon, 02/19/18 - 11:42 am
AstraZeneca
FDA
Imfinzi
non-small cell lung cancer
AstraZeneca's Tagrisso Label Expansion Filing Accepted by FDA
Yahoo/Zacks.com
Tue, 12/19/17 - 10:24 am
AstraZeneca
Tagrisso
FDA
labeling
non-small cell lung cancer
Most Damaging Clinical Trial Failure: AstraZeneca's MYSTIC
BioPharma Dive
Mon, 12/4/17 - 09:42 pm
clinical trials
AstraZeneca
Mystic
Imfinzi
non-small cell lung cancer
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »